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A retrospective analysis was undertaken to define the
natural history and long-term follow-up of a group of
patients with Marfan's syndrome . Eighty-four patients
were diagnosed between January 1959 and June 1987 as
having Marfan's syndrome ; 68% were male; their ages
ranged from to 67 years (mean 6.6) . Sixteen patients
constituted the early surgical group (those who underwent
surgery before 1979 ; mean age 36 .1 years). Nineteen pa-
tients constituted the late surgical group (surgery in 1979 or
later; mean age 33 .3 years) . The nonsurgical group com-
prised 49 patients (mean age 19 .3 years) .
Fifty-seven percent of the patients had a diastolic mur-
mur and 38% had cardiomegaly at presentation . Fifty-
seven percent underwent cardiac catheterization, which
revealed aortic root dilation (85%), aortic regurgitation
(73%), aortic dissection (33%) and mitral regurgitation
(36%). Thirteen of the 19 patients in the late surgical group
received a composite graft repair of the ascending aorta as
compared with only of the 16 in the early surgical group .
Follow-up information was obtained on 81 (96%) of 84
The Marfan syndrome is a heritable disorder of connective
tissue with protean clinical manifestations involving the
ocular, skeletal and cardiovascular systems . It is well estab-
lished that patients with cardiovascular involvement have a
decreased life expectancy (1) that is due mainly to progres-
sive aortic root dilation with a propensity toward aortic
dissection, rupture or regurgitation .
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patients ; the follow-up time was to 33 months (mean 99) .
Thirty-one of the 81 patients died at age 3 to 63 years (mean
age 35 years) ; 87% of the known causes of death were
related to the cardiovascular system . Sixty-one percent of
deaths were the result of aortic dissection or rupture or
sudden cardiac death . Of the 50 survivors, 98%, including
all patients in the late surgical group, were in functional
class I or II . Overall survival at 5, 10 and 15 years after
operation was 78 .4%, 57.1% and 49.5%, respectively . The
presence of a diastolic murmur or cardiomegaly, or both, at
presentation was associated with poor prognosis, which can
be attributed to aortic insufficiency .
There was a definite improvement in survival of patients
operated on in 1979 or later as compared with survival of
patients in the early surgical group (87 .5 % survival at 5
years versus 56%, respectively) . The improved survival in
the late surgical group is attributable to earlier and more
extensive surgery utilizing a composite graft with reimplan-
tation of the coronary arteries as the procedure of choice .
(J Am Coll Cardiol 1989 ;14:4 -8)
Early reports ( ) stated that cardiovascular manifesta-
tions occur in 30% to 60% of patients with Marfan's syn-
drome. Our ability to detect these abnormalities improved
greatly with the advent of echocardiography and more
sophisticated diagnostic techniques . Echocardiographic ev-
idence of cardiovascular involvement exists in >95% of
adults with Marfan's syndrome and is universal in children
with this syndrome (3-8) .
Few studies have dealt with the natural history and
long-term follow-up of a group of patients with Marfan's
syndrome. In this report we describe the Cleveland Clinic
experience with this disease entity . Early surgical (before
1979), late surgical (in 1979 or later) and nonsurgical groups
are compared to gain insight into the natural history and
long-term clinical outcome of our patient population .
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Methods
Selection of patients . A retrospective analysis was under-
taken of all patients with Marfan's syndrome seen at the
Cleveland Clinic Foundation between January 1959 and June
1987. The diagnosis of Marfan's disease was based on family
history and the usual clinical findings of ocular, skeletal and
cardiovascular abnormalities ; at least two or three of these
major categories were required (3) . In patients with a posi-
tive family history, involvement of at least two major sys-
tems was required and "soft" signs (myopia, mitral valve
prolapse) were considered acceptable criteria . Stricter re-
quirements were applied to patients who lacked a positive
family history . In addition to skeletal involvement, evidence
of ectopia lentis or aortic root dilation, or both, was re-
quired . Patients with a "marfanoid" habitus but no addi-
tional "hard" signs were excluded even if myopia or mitral
valve prolapse was present .
Follow-up . Data were collected for follow-up by contact-
ing the patient or relatives if the patient was not available or
had died, reviewing all charts and consulting the referring
physicians . The cause of death was obtained from charts,
death certificates, autopsy reports when available, referring
physicians and relatives . To follow the long-term outcome as
well as the natural history of this disease, patients were
placed in three groups : nonsurgical, early surgical (patients
operated on before 1979) and late surgical (patients operated
in 1979 or later) .
Statistics . Demographic and clinical factors for the treat-
ment groups were compared with use of chi-square analysis
for categorical data . Continuous data were evaluated by
analysis of variance and multiple comparison techniques .
Survival curves were created by using Kaplan-Meier esti-
mates. The log-rank test was used to test for differences
between estimated survival curves . A separate analysis
compared patients who presented with or without a positive
family history of Marfan's syndrome . All statistical analyses
were performed with use of the SAS statistical software
package (9) . Data are presented as mean values ± SD .
Results
Study patients . Between January 1959 and June 1987, 84
patients were diagnosed as having Marfan's syndrome ; 68%
were male . The mean age was 5 years (range I to 66) .
These patients were classified into three
groups . The
nonsurgical group comprised 49 patients who did not un-
dergo a surgical procedure in the study period ; this group
had a mean age of 19.3 years (range 1 to 53) . The early
surgical group comprised 16 patients who underwent surgery
before 1979 (mean age 35 .6 years, range 15 to 53) . The late
surgical group comprised 19 patients who underwent surgery
after 1979 (mean age 3 .9 years, range to 66) . Most patients
who underwent surgery were in the 4th decade of life ;
nonsurgical patients were a much younger group (by some 15
years) .
Clinical characteristics (Table 1) . All of our 84 patients
met at least two or three of the major diagnostic criteria for
Marfan's syndrome (3) . The prevalence of a positive family
history was 38% . Thirty-eight percent of our patients had
ectopia lentis and 39% had myopia . Thirty-three percent of
the patients underwent a formal ophthalmologic evaluation
with a slit-lamp examination . The skeletal manifestations are
as outlined; 65% had a pectus deformity (excavatum/
carinatum), 57% had arachnodactyly and 43% had kypho-
scoliosis .
On presenting cardiac examination, 74% of patients had
a systolic and 57% a diastolic murmur. Only 36% of the
patients in the nonsurgical group had a diastolic murmur at
presentation, compared with 93% of the patients in the early
surgical group and 76% of these in the late surgical group .
The initial chest X-ray film revealed that cardiomegaly
was more prevalent in the surgically treated patients ; it was
noted in 60% and 56%, respectively, of patients in the early
and late surgical group but in only % of patients in the
nonsurgical group . Only 5% of patients in the nonsurgical
group presented with a dilated aortic arch . This finding was
much more common in the surgically treated patients, par-
ticularly those in the early surgical group (59%) .
The presenting electrocardiogram revealed normal sinus
rhythm in 90% of our patients . Left ventricular hypertrophy
was present in 6% and left atrial enlargement in 1% .
Echocardiography was performed in only 50% of our
patients, in part because it was not available to most patients
in the early years of our study . However, of the 44 patients
who had echocardiograms, 9 (66%) had an abnormal aortic
root or valve . Diastolic flutter of the anterior mitral leaflet
was present in 19 (44%) of these 44 patients, suggesting the
presence of aortic insufficiency, and 7 (6 %) of these 44
patients had mitral valve prolapse .
Fifty-six percent of the patients underwent cardiac cath-
eterization .Two patients had digital subtraction angiography
of the aorta . Only 14% had coronary artery disease, 36% had
mitral regurgitation and 68% had a dilated left ventricle . All
Table 1 . Clinical Characteristics of 84 Patients With
Marfan's Syndrome
Family history
38%
Musculoskeletal
Kyphoscoliosis 43%
Arachnodactyly
57%
High arched palate 48%
Pectus deformity
65%
Hyperextensible joints 33%
Ocular
Ectopia lentis
38%
Myopia 39%
Slit-lamp examination 35%
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Table . Surgical Procedures in 35 Patients
patients in the early surgical group with catheterization and
89% of those in the late surgical group had aortic root
dilation (mean 4 .8 cm, range . to 8.0) . No patient in the
nonsurgical group had evidence of aortic dissection as
compared with 53% and 41%, respectively, of patients in
early and late surgical groups. Aortic regurgitation was
present in 44% of the nonsurgical group, 93% of the early
surgical group and 83% of the late surgical group .
Surgical procedures (Table ). Two patients in the early
surgical group received a composite graft, or valved conduit,
with reimplantation of the coronary arteries . One of these
two patients had a poor outcome after undergoing an emer-
gency procedure . Thirteen of the 19 patients undergoing late
surgery received a composite graft . The majority of patients
treated surgically before 1979 underwent aortic valve re-
placement with resection of the aortic aneurysm and an end
to end anastomosis. No patient in the late surgical group
underwent this procedure . Several patients in both groups
underwent mitral valve replacement, and several other sur-
gical procedures, including coronary artery bypass surgery,
were performed in the late surgical group .
The indication for surgery was aortic dissection in nine
patients in the early surgical group but in only five patients in
the late surgical group . Six patients in the early group had an
ascending aortic aneurysm with aortic regurgitation, as
compared with nine patients in the late group . Several
patients in both groups had mitral regurgitation and three
patients in the late surgical group had other indications for
surgery, including coronary artery disease .
Follow-Up
Follow-up data were obtained in 81 (96%) of the 84
patients
. The follow-up period ranged from to 33 months
(mean 99 months or 8
.3 years) .
Causes of death (Fig. 1) . There were 31 deaths in the 84
patients . The mean age at death was 35 years (range 3 to 6 ) .
Almost 50% of the patients died as a result of involvement of
the aorta, by either dissection or rupture, and death in an
additional 13% was defined as a sudden cardiac death .
Thirteen percent died of congestive heart failure, 10% of
myocardial infarction and 16% of other causes including lung
cancer, renal failure, injuries in a motor vehicle accident,
head trauma and unknown cause (one patient) .
AORTIC
DISSECTION
OTHERS
or 16%
RUPTURE
48%
SUDDEN DEATH
or
CARDIAC ARREST
13%
Figure 1 . Causes of death for 81 of 84 patients with Marfan's
syndrome . Eighty-seven percent of the known causes of death were
attributable to involvement of the cardiovascular system . CHF =
congestive heart failure .
In the nonsurgical group, 50% of deaths were due to
aortic root disease ; sudden cardiac death occurred in one
additional . In contrast, there was a disproportionately higher
incidence of deaths related to aortic root involvement and
sudden cardiac death in the early surgical group. Eleven of
the 15 patients in this group died suddenly of cardiac causes
or as a result of aortic rupture or dissection, or suture
dehiscence. The combined cardiovascular mortality in this
group was 93% . Thus far there have been only two deaths in
the late surgical group, but the longest follow-up period in
this group has been 5 .8 years . One of the two patients died of
myocardial infarction caused by fibrosis at the coronary
reimplantation site, the other died of noncardiac causes .
Survival data . There were 50 survivors among 81 pa-
tients. Ninety-eight percent of all 50 patients were in func-
tional class I or II ; only one patient is in functional class IV .
All patients in the late surgical group were in functional class
I or II .
The estimated overall survival of 81 of the 84 patients at
5, 10 and 15 years was 78 .4%, 57.1% and 49.5%, respectively
(Fig . ) . There was a slight advantage (p = NS) in survival
for female gender
. In addition, there was no difference
between the survival curves of patients who presented with
a positive family history versus those who did not .
Figure 3 compares survival of the three treatment
groups . Those patients undergoing surgery in 1979 or later
have the best survival ratio (estimated to be 88% at 5 years
after surgery)
. In sharp contrast, 15 of 16 patients who
underwent surgery before 1979 have died ; the estimated
survival of this early surgical group is 56% at 5 years. The
difference in estimated survival between the early and late
surgical groups is only marginally significant (p = 0
.11). The
survival for the nonsurgical group is similar to that of the late
surgical group at 5 years (84%) and is 61% at 0 years of
follow-up. The duration of follow-up for the three groups is
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Figure . Overall survival of 81 of the 84 patients . Estimated (EST)
survival at 5, 10 and 15 years is 78.4%, 57 .1% and 49.5%, respec-
tively . The number of patients remaining at risk for each follow-up
interval is noted .
136 ± 104 months for the nonsurgical group, 77 ± 66 months
for the early surgical group and 3 ± 4 months for the late
surgical group .
Figure 4 compares survival of patients who did or did not
have a diastolic murmur at presentation . The presence of a
diastolic murmur was associated with a poor prognosis, as
was the development of cardiomegaly (Fig . 5). Univariate
analysis showed that a diastolic murmur (p < 0 .0001) and
cardiomegaly (p < 0 .0009) were significantly related to long-
term survival .
Discussion
Diagnostic features . Pyeritz and McKusick (3) have set
forth rigid criteria for the diagnosis of Marfan's syndrome .
These include the presence of 1) ocular manifestations
(ectopia, lentis, myopia) ; ) skeletal manifestations (pectus
Figure 3 . Estimated (EST) survival by treatment group in
84 pa-
tients . Patients who underwent surgery since 1979
have the best
survival (87.5% survival 5 years after surgery) . Fifteen of the 16
patients who underwent surgery before 1979 (early surgical group)
had died by 0 years of follow-up . Survival of the nonsurgical group
is as illustrated .
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Figure 4. Estimated (EST) survival in patients who presented with
a diastolic murmur and in those who did not . The presence of a
diastolic murmur on initial cardiac examination was associated with
a poor prognosis (p < 0 .0001) .
deformity, dolichostenomelia, arachnodactyly, kyphoscoli-
osis, high arched palate, hyperextensible joints) ; 3) cardio-
vascular manifestations (aortic root dilation, aneurysm, dis-
section or regurgitation, and mitral valve prolapse with or
without regurgitation) ; and 4) a positive family history . All of
our patients met at least two or three of these four major
criteria for the diagnosis of Marfan's syndrome (3) .
Only 38% of our patients had a positive family history .
This prevalence is significantly lower than that of other
series in which the prevalence ratio of 60% to 85% is
consistent with an autosomal dominant pattern of transmis-
sion (3) . The low prevalence in our study most likely reflects
inadequate history taking rather than spontaneous genetic
mutation, which is estimated to occur in 15% of cases (10) .
Similarly, the prevalence of ectopia lentis in our patients
was much less than the 50% to 80% estimated by Pyertiz and
McKusick (3) . This lower prevalence correlates with the fact
that only 33% of our patients underwent formal ophthalmo-
Figure 5 . Estimated (EST) survival in patients with or without
cardiomegaly . The development of cardiomegaly was associated
with a decreased long-term survival (p < 0 .0009) .
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logic evaluation with a slit-lamp examination
. Subtle sublux-
ation of the lens may have escaped detection in our patients .
The prevalence of skeletal manifestations was also lower
than expected . This result is due to the lack of a systematic,
consistent approach toward patient evaluation and data
collection
. The initial history and physical examination were
recorded by a variety of physicians (general practitioners,
pediatricians, internists, ophthalmologists, orthopedists,
cardiologists) with varying degrees of expertise on Marfan's
syndrome .
Noncardiac findings, although essential in making the
diagnosis, had little impact on long-term survival . Specifi-
cally, the presence of ocular and skeletal abnormalities was
not associated with a poor prognosis .
Prognostic predictors . The presence of a diastolic mur-
mur on initial physical examination was associated with a
decreased long-term survival . This association is most likely
attributable to the presence of aortic insufficiency secondary
to a dilated aortic root at presentation . Ninety-three percent
of patients in the early surgical group (surgery before 1979)
had a diastolic murmur and 15 of these 16 patients have died .
Patients in the nonsurgical group with a diastolic murmur
had a poorer outcome as well . Although 74% of patients in
all groups presented with a systolic murmur, this did not
correlate with survival .
The presence of cardiomegaly on presenting chest X-ray
film was also associated with poor long-term survival and
this finding applied to the nonsurgical group as well . Again
we attribute this association to longstanding aortic regurgi-
tation . To the best of our knowledge, the association of a
diastolic murmur or cardiomegaly, or both, with a poor
prognosis has not been previously described
. These findings
may be markers for more serious disease expression with
involvement of the aorta at presentation and a tendency
toward aortic dissection, rupture or regurgitation . These
findings are also in accord with previously published data
(11,1 ) regarding the poorer prognosis in patients with car-
diomegaly and congenital heart disease .
Diagnostic procedures . The presence of a diastolic mur-
mur or cardiomegaly, or both, on initial evaluation should
alert the examining physician to proceed in an aggressive
manner with respect to further management . Once a dilated
aortic root is demonstrated by baseline echocardiography, a
contrast study to visualize the entire aorta should be per-
formed
. We (13) have shown that intravenous digital sub-
traction aortography is an effective means of following up
patients with Marfan's disease, but cine magnetic resonance
imaging is the diagnostic procedure of choice at our institu-
tion. Close serial follow-up, initially at 6 month intervals,
should be instituted and consideration should be given to
early surgical intervention when indicated. We agree with
the recommendation of Gott et al . (14) for prophylactic
repair even in asymptomatic patients when the aneurysm
reaches a diameter of 6 cm . This approach must be tailored
to individual patients taking into consideration the rate of
progression of aortic root dilation .
Echocardiograms were not obtained on most patients in
this series, in part because this technology was unavailable
to some of the patients seen earlier in the study
. In those
patients in whom echocardiography was performed, the
most consistent finding (57% of patients) was an abnormal
aorta and aortic valve . The usefulness of this method of
examination correlates with the finding by Pyeritz and
McKusick (3) that only 3 of 150 patients examined had a
normal echocardiogram . The prevalence rate of mitral valve
prolapse in our patients was 6 % and similar to that previ-
ously reported (4,15) .
Causes of death . Patients with cardiovascular manifesta-
tions have a decreased life expectancy . In the study of 57
patients by Murdoch et al . (1), cardiovascular manifestations
accounted for 93% of the deaths in those whose cause of
death was known (5 of 56 patients) . Aortic root complica-
tions (dilation, dissection and regurgitation) accounted for
80% of these deaths (39 of 56 patients) . Other deaths were
attributed to congestive heart failure, presumably due to
aortic insufficiency . The average age at death of the 7
patients who died was 3 years (1) .
These findings are very similar to those found in our
patients, whose mean age at death was 35 years . Eighty-
seven percent of the known causes of death were related to
the cardiovascular system . Sixty-one percent were the result
of aortic dissection, rupture or sudden cardiac death . Other
causes included congestive heart failure and myocardial
infarction . The high mortality rate may in part reflect selec-
tion bias toward a more severe form of the disease as our
institution remains a major referral center for complex
cardiovascular disease .
Role of surgical therapy in patient survival . In comparing
treatment groups (Fig. 3), there appears to be a dramatic
improvement in survival among those patients undergoing
surgery after 1979 as compared with that in patients in the
early surgical group . However, the difference between early
versus late surgery was only marginally significant (p = 0 .11)
for the first 5 years . This outcome was most likely due to the
small number of patients as well as much greater length of
follow-up for the early surgical group . Patients in the late
surgical group have been monitored for <_5
.8 years . Addi-
tional follow-up, particularly in the late surgical group, is
needed to better delineate the "natural history" in our
population .
We attribute the trend toward improved survival in the
late surgical group to better surgical technique utilizing a
composite graft or valved conduit, with reimplantation of the
coronary arteries as the procedure of choice . All patients in
the late surgical group requiring aortic reconstruction re-
ceived a composite graft
; the group has an estimated survival
rate of 88% 5 years after surgery
. In sharp contrast, of
patients undergoing surgery before 1979, 15 of 16 have died
.
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The majority of patients in the early surgical group under-
went aortic valve replacement with resection of the aortic
aneurysm and end to end anastomosis . This more primitive
operation preserved a "cuff" of native aortic tissue, hence,
these patients were prone to suture line dehiscence, redis-
section and rupture (14,16,17) . There was a disproportion-
ately higher incidence of deaths related to aortic root in-
volvement in the early surgical group, and the combined
cardiovascular mortality in this group was 93% . Other fac-
tors contributing to improved survival in the late surgical
group include a trend toward earlier, and in some cases,
prophylactic surgery as the patients in this group were
slightly younger and had a lower incidence of aortic dissec-
tion. The role that beta-adrenergic blocker therapy may play
in the improved survival of our late surgical patients remains
undefined and needs further study .
The improved survival associated with composite graft
repair of the aorta in patients with Marfan's syndrome has
been well established (14,17) . Gott et al. (14) described the
preoperative and long-term postoperative status of 50 con-
secutive patients receiving a composite graft repair for
Marfan's aortic disease. The mean age at surgery was 3 .
years ; the mean aortic diameter was 7 .1 cm (range 5 .3 to 10) .
Fourteen patients had evidence of aortic dissection including
5 with acute dissection . The others have "chronic" dis-
section . The in-hospital mortality rate was % and the
actuarial survival rate was 87% at and 5 years, which is
similar to our estimated survival rate . With such low oper-
ative and long-term mortality, the authors suggest prophy-
lactic repair in light of the unfavorable natural history of
Marfan's syndrome (14) . Our findings would support this
view .
Survival in the nonsurgical group . Although the estimated
survival of the nonsurgical group is similar to that of the late
surgical group at 5 years (84% and 88%, respectively), it is
only 61% at 0 years of follow-up . This figure represents a
significant mortality rate for such a young group of patients
(mean age 19 .3 years at presentation) and may suggest that in
these patients with more complete disease expression who
were prone to aortic root involvement that its complications
have become manifest. This suggestion would correlate with
the 36% incidence of a diastolic murmur in this group at
presentation . It will be interesting to note whether there is
further decline in this survival curve with time . The mean
age of the nonsurgical group at last follow-up was 30 .5 years .
These patients may be approaching the stage in their disease
process where aortic root complications and other cardio-
vascular morbidity are apt to develop, because those pa-
tients who underwent surgery were in their 4th decade of
life .
Role of beta-blocker therapy . Finally, only 38% of our
patients received beta-blocker therapy . Again this figure
reflects a varied physician experience and suffers from the
limitations of a retrospective analysis . Some authors (18)
suggest that beta-blockers appear to have a beneficial effect
in retarding or delaying aortic root disease in patients with
Marfan's syndrome . No controlled clinical trials are avail-
able as yet. We currently employ beta-blocker therapy in our
patients with Marfan's syndrome who have evidence of
aortic root involvement and in our surgical patients before
and after operation .
Conclusions. Marfan's syndrome continues to be a
"silent killer" among young patients because of its cardio-
vascular manifestations . We and others have shown that
87% of the known causes of death are related to the
cardiovascular system . The vast majority of these are due to
aortic root complications (aortic dissection, rupture or re-
gurgitation) . Furthermore, the presence of a diastolic mur-
mur or cardiomegaly, or both, on presentation is associated
with a poor long-term prognosis . This association is most
likely attributable to long-standing aortic insufficiency from
aortic root dilation . These findings should direct appropriate
diagnostic and therapeutic management .
There appears to be an improvement in survival in
patients undergoing surgery after 1979 . Early and aggressive
surgical intervention utilizing a composite graft with reim-
plantation of the coronary arteries as the procedure of choice
may be essential in altering the "natural history" of this
disease. Further follow-up, particularly of our late surgical
group, is necessary to better delineate this . Early detection
and close serial follow-up are critical in the care of these
patients .
We are indebted to Jo Rolph and Kathy Shupe for expertise in the preparation
of the manuscript .
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